Are you a MedTech manufacturer interested in the Chinese market but concerned about regulatory hurdles? China’s insatiable healthcare demand continues to grow and the regulatory environment is fast changing.
In this exclusive virtual seminar, Cisema analyses and describes the medical market opportunities, provides an overview over regulatory hurdles and on how to register your MedTech products for sale in China with the NMPA (former CFDA), and provides insight into China’s complex regulatory landscape with its increasing focus on the entire product life and post-market surveillance for MedTech in China.
You can find the flyer for the virtual seminar on the right in the download area. It tells you something about the program.
Link to other virtual seminars of SPECTARIS GmbH: https://www.spectaris.de/medizintechnik/veranstaltungsuebersicht/
Important note: All speakers are happy to receive your specific questions in advance.
for SPECTARIS member: net 99,00 Euro
for non SPECTARIS members: net 149,00 Euro
Registration takes place via: https://eveeno.com/medtech_china.